# The Effect of Intravenous EACA on Blood Loss and Transfusion Requirements After Bilateral VRO

> **NCT02257580** · PHASE4 · COMPLETED · sponsor: **Hospital for Special Surgery, New York** · enrollment: 28 (actual)

## Conditions studied

- E-Aminocaproic Acid
- Bilateral Varus Rotational Osteotomy

## Interventions

- **DRUG:** E-Aminocaproic acid

## Key facts

- **NCT ID:** NCT02257580
- **Lead sponsor:** Hospital for Special Surgery, New York
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-01
- **Primary completion:** 2020-10-26
- **Final completion:** 2020-10-26
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2022-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02257580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02257580, "The Effect of Intravenous EACA on Blood Loss and Transfusion Requirements After Bilateral VRO". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02257580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*